1Klauber N,Parangi S,Flynn E,et al.Inhibition of angiogenesis and breast cancer in mice by the microtllbule inhibitors 2-methoxyestradiol and taxol.Cancer Res,1997,57(1):81-86.
2Ajani JA,Ilson DH,Dangherty K,et al.Activity of taxol in patients squamons cell carcinoma and adenocarcinoma of the esophagus.J Natl,1994,86(4):1086-1091.
3Ilson DH,Ajani J,Bhalla K,et al.Phase Ⅱ trial of paclitaxel,fluorouracil,and cisplatin in patients with advanced carcinoma of the esophagus.J Clin Oncol,1998,16(5):1826.
5Klauber N, Parangi S, Flynn E, et al. Inhibition ofangiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol[J]. Cancer Res, 1997, 57(1): 81-6.
6[1]Ajani JA,Ilson DH,Daugherty k,et al.Activity of Taxol in patient with squamous cell carcinoma and adenocarcinoma of the esopha gus.J Natl Cancer Inst,1994,86:1086
7[2]Ajani JA.Treatment of patient with upper gastrointestinal carcino ma.Semin Oncol.1997,24(supple 19):726
8[5]Ajani JA.Contribution of chemotherapy in the treatment of carci noma of the esophagus:results and commentary.Semin Oncol,1994,21 (4):474
9[6]Van der Gaast A.A phase Idose finding study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paoli taxel in patients with advanced esophageal cancer.SeminOncol,1997,24(supple 19):82
10[7]Ilson DH.Phase Ⅱ trial of paclitaxel,fluorouracil and cisplatin in patients with advanced carcinoma of the esophagus.J Clin Oncol,1998,16:1826
